(04/09)

Hay fever can be the most debilitating condition for a child not only making them feel awful but preventing them sleeping, and affecting both their social lives and school work. Children with hay fever are 40% more likely to drop a grade between their mock GCSE exams (in the winter) and their final exams (in peak hay fever season) than their hay fever-free peers.

For many years the only treatment for the condition has been antihistamines, which often cause drowsiness and do nothing to address the underlying problem. So the development of a childrens’ version of the successful immunotherapy treatment, Grazax, will be enthusiastically welcomed by thousands of sneezing families – especially since Grazax is administered as a pill under the tongue rather than being injected under the skin.

Studies on adults have shown not only a significant decrease in symptoms while taking Grazax but that the improvement holds for several years afterwards. A recent study on children at the Ruhr University in Germany showed that hay fever symptoms were 24% less pronounced in children taking Grazax than in those who were not.
NHS financial boffins have computed that, at £2.25 a day, Grazax is a more cost-effective way of dealing with childhood hay fever than the current range of treatments. What good news!
www.grazax.com

Click here for more research on infant and child

Top of page